Harrow Inc. Insider Trading

HROW

Last 12 months

Insiders bought 469K and sold 450K on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Chief Scientific Officer Amir Shojaei sold 450K on Aug 14, 100% of their stake, outside a plan.

Net open-market

+19K

4 buys · 1 sale

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

4 / 1

executives and directors

Last open-market buy

May 2026

May 18, 2026

Get an email when HROW's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 14	Amir Shojaei Chief Scientific Officer	SoldNo plan	11,250	$40.00	450K	100%	Form 4
May 18	Adrienne L Graves Director	Bought	1,000	$31.07	31K	New	Form 4
May 18	Lauren P Silvernail Director	Bought	1,000	$31.00	31K	New	Form 4
May 14	Mark L Baum Chief Executive Officer	Bought	10,000	$30.20	302K	0.3%	Form 4
May 14	Andrew R. Boll President and CFO	Bought	3,500	$29.90	105K	0.4%	Form 4
Mar 3 – 4	Opaleye Management Inc. Large holder	SoldNo plan 4 parts	198,572	$39.51 average	$7.85M	5.1%	Form 4
Feb 27	Opaleye Management Inc. Large holder	SoldNo plan	5,000	$54.18	271K	0.1%	Form 4
Jan 6	Opaleye Management Inc. Large holder	SoldNo plan	20,000	$53.35	$1.07M	0.5%	Form 4
Jun 9, 2025 – Jun 10, 2025	Opaleye Management Inc. Large holder	SoldNo plan 2 parts	30,204	$30.58 average	924K	0.8%	Form 4
Jun 3, 2025 – Jun 4, 2025	Opaleye Management Inc. Large holder	SoldNo plan 2 parts	4,796	$30.03 average	144K	0.1%	Form 4
May 12, 2025 – May 13, 2025	Opaleye Management Inc. Large holder	SoldNo plan 2 parts	15,000	$26.13 average	392K	0.4%	Form 4
Mar 24, 2025	Opaleye Management Inc. Large holder	SoldNo plan	5,000	$30.01	150K	0.1%	Form 4
Mar 18, 2025	Opaleye Management Inc. Large holder	SoldNo plan	5,000	$29.64	148K	0.1%	Form 4
Mar 18, 2025	Opaleye Management Inc. Large holder	SoldNo plan	5,000	$29.64	148K	0.1%	Form 4
Feb 28, 2025	Opaleye Management Inc. Large holder	SoldNo plan	5,000	$28.05	140K	3.2%	Form 4
Jan 22, 2025	Opaleye Management Inc. Large holder	SoldNo plan	20,000	$35.59	712K	11%	Form 4

Aug 14No plan
Amir Shojaei
Chief Scientific Officer · sold 11,250 at $40.00
450K
100% of stake
May 18
Adrienne L Graves
Director · bought 1,000 at $31.07
31K
New position
May 18
Lauren P Silvernail
Director · bought 1,000 at $31.00
31K
New position
May 14
Mark L Baum
Chief Executive Officer · bought 10,000 at $30.20
302K
0.3% of stake
May 14
Andrew R. Boll
President and CFO · bought 3,500 at $29.90
105K
0.4% of stake
Mar 3 – 4No plan
Opaleye Management Inc.
Large holder · sold 198,572 at avg $39.51
$7.85M
5.1% of stake
Feb 27No plan
Opaleye Management Inc.
Large holder · sold 5,000 at $54.18
271K
0.1% of stake
Jan 6No plan
Opaleye Management Inc.
Large holder · sold 20,000 at $53.35
$1.07M
0.5% of stake
Jun 9, 2025 – Jun 10, 2025No plan
Opaleye Management Inc.
Large holder · sold 30,204 at avg $30.58
924K
0.8% of stake
Jun 3, 2025 – Jun 4, 2025No plan
Opaleye Management Inc.
Large holder · sold 4,796 at avg $30.03
144K
0.1% of stake
May 12, 2025 – May 13, 2025No plan
Opaleye Management Inc.
Large holder · sold 15,000 at avg $26.13
392K
0.4% of stake
Mar 24, 2025No plan
Opaleye Management Inc.
Large holder · sold 5,000 at $30.01
150K
0.1% of stake
Mar 18, 2025No plan
Opaleye Management Inc.
Large holder · sold 5,000 at $29.64
148K
0.1% of stake
Mar 18, 2025No plan
Opaleye Management Inc.
Large holder · sold 5,000 at $29.64
148K
0.1% of stake
Feb 28, 2025No plan
Opaleye Management Inc.
Large holder · sold 5,000 at $28.05
140K
3.2% of stake
Jan 22, 2025No plan
Opaleye Management Inc.
Large holder · sold 20,000 at $35.59
712K
11% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch HROW, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with HROW

CompareIntrinsic value

RIGLRigel Pharmaceuticals, Inc.

$51.29+4.97%87

LQDALiquidia Corporation

$47.38+12.27%72

LGNDLigand Pharmaceuticals Inc.

$316.13+0.83%36

SDGRSchrodinger, Inc.

$28.52+4.93%36

SNDXSyndax Pharmaceuticals Inc.

$10.45-26.87%0

RYTMRhythm Pharmaceuticals Inc.

$110.68+28.04%40

AUPHAurinia Pharmaceuticals Inc.

$17.11+3.32%58

PHATPhathom Pharmaceuticals Inc.

$5.68-1.05%10

Held by ETFs

HROW is in 32 US ETFs. The largest of them, with HROW's weight in each:

Spot a number that looks wrong? Check it in HROW's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing HROW

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.